economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

pipeline

129Knots Founded by Indian-Origin Entrepreneurs Launches First of its Kind OTD Technology with USD 10M Investment and USD 500M Deal in Pipeline OG_Multimedialog_93291.jpg

129Knots Founded by Indian-Origin Entrepreneurs Launches First of its Kind OTD Technology with USD 10M Investment and USD 500M Deal in Pipeline

creativebharatgroup@gmail.com January 27, 2025
New Delhi, Delhi, India:   Global fintech venture 129Knots, founded by Indian-origin leaders,...
Read More Read more about 129Knots Founded by Indian-Origin Entrepreneurs Launches First of its Kind OTD Technology with USD 10M Investment and USD 500M Deal in Pipeline
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas OG_NewsReleaseCompanyLogo_92862.jpg

Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

creativebharatgroup@gmail.com December 13, 2024
Osaka, Japan & Cambridge, Mass., United States:    Six Late-Stage Programs with...
Read More Read more about Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets OG_NewsReleaseCompanyLogo_92796.jpg

BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets

creativebharatgroup@gmail.com December 10, 2024
San Mateo, Calif., United States:   5-year follow-up from SEQUOIA study demonstrated...
Read More Read more about BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets